Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01103258
Other study ID # MEC 05-2-014
Secondary ID ZON MW 4636
Status Completed
Phase N/A
First received April 6, 2010
Last updated April 12, 2010
Start date February 2006
Est. completion date January 2010

Study information

Verified date April 2010
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

Varicose vein disease is a common health problem, which causes much discomfort to patients.

Nowadays treatment modalities for greater saphenous veins include surgery and duplex guided foam sclerotherapy. These are two equally accepted and applied treatments for the same patient population.

Choice of treatment often depends on the referral preference of the General Practitioner. Until now data are missing which treatment is more cost effective. The current proposal aims at comparing the effects, costs and patient preferences between duplex guided foam sclerotherapy and surgery in the treatment of greater varicose veins.


Recruitment information / eligibility

Status Completed
Enrollment 460
Est. completion date January 2010
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- incompetence of great saphenous vein for minimal 20 cm

- life expectancy at least 3 years

- open and competent deep venous system

- willing to undergo both treatments

Exclusion Criteria:

- active ulcer

- signs of deep venous thrombosis with duplex

- incompetence of the deep venous system

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
high ligation and stripping (surgery)
surgery consisting of high ligation in combination with long saphenous stripping
FOAM
duplex guided foam sclerotherapy

Locations

Country Name City State
Netherlands Maastricht UMC Maastricht

Sponsors (2)

Lead Sponsor Collaborator
Maastricht University Medical Center ZonMw: The Netherlands Organisation for Health Research and Development

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary cumulative probability of recurrent varicose vein within 24 months after treatment 24 months No
Secondary quality of life (as measured by EuroQol-5D) 24 months No
Secondary patient preferences (as measured by conjoint analysis) 24 months No
Secondary direct Health care costs materials, operation costs, personnel costs 24 months No